Generex Biotechnology (QB) Stock Price

-0.00706 (-2.48%)


52 Week Range


Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Generex Biotechnology Corporation (QB) GNBT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00706 -2.48% 0.2772 16:09:14
Open Price Low Price High Price Close Price Prev Close
0.2736 0.2711 0.29 0.2772 0.28426
Bid Price Ask Price Spread News
0.271 0.28 0.009 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
67 180,344 $ 0.281323 $ 50,735 - 0.165 - 0.85
Last Trade Time Type Quantity Stock Price Currency
15:54:09 200 $ 0.2772 USD

Generex Biotechnology (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 32.21M 116.19M 98.36M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
223.92k $ - 0.00% - -

more financials information »

Generex Biotechnology (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GNBT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2780.330.260.2771851398,186-0.0008-0.29%
1 Month0.28550.330.250.2733584308,747-0.0083-2.91%
3 Months0.42110.480.250.3420187444,090-0.1439-34.17%
6 Months0.1990.750.180.326434713,4960.078239.3%
1 Year0.460.850.1650.3437498715,243-0.1828-39.74%
3 Years2.7025.300.1650.6699536357,913-2.42-89.73%
5 Years6.0025.300.1650.6783848261,516-5.72-95.38%

Generex Biotechnology (QB) Description

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

Your Recent History
Generex Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.